Stock INVO INVO BIOSCIENCE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages INVO Bioscience, Inc.

Equities

INVO

US44984F4019

Market Closed - Nasdaq
Other stock markets
 21:00:00 15/05/2024 BST 		5-day change 1st Jan Change
1.07 USD -4.46% Intraday chart for INVO Bioscience, Inc. +15.05% -20.74%
04-18 Top Premarket Decliners MT
04-17 Sector Update: Health Care Stocks Retreating Late Afternoon MT

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
INVO Bioscience, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
NAYA Biosciences Inc. Announces Publication of New Data for its CD38-targeted Flex-NK Bispecific Antibody in the American Society of Hematology's Blood Journal
Top Premarket Gainers
INVO Bioscience, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Wall Street Set to Open Slightly Higher as Investors Parse Powell Remarks
Sector Update: Health Care Stocks Softer Late Afternoon
Sector Update: Health Care Stocks Mixed in Monday Afternoon Trading
INVO Bioscience Shares Skyrocket After Signing Deal to Buy NAYA Biosciences
Wall Street Set to Open Lower Monday as National Activity Index Shows Near-Historic Economic Growth
INVO Bioscience, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
INVO Bioscience Closes Wisconsin Fertility Institute Acquisition
Top Midday Decliners
INVO Bioscience, Inc. Receives 510(K) FDA Clearance for Expanded Use of the Invocell Device
INVO Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
INVO Bioscience, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
INVO Bioscience, Inc. Auditor Raises 'Going Concern' Doubt
INVO Bioscience, Inc. Announces Resignation of Jeffrey Segal as A Director
INVO Bioscience, Inc. Provides Earnings Guidance for the Fourth Quarter and Year Ended December 31, 2022
INVO Bioscience Closes $3 Million Registered Direct Offering
Sector Update: Health Care Stocks Higher in Late Afternoon Trading
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. INVO Stock
  4. News INVO Bioscience, Inc.
  5. Other languages